AAAAAA

   
Results: 1-7 |
Results: 7
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study
Authors: Blau, IAW Basara, N Lentini, G Guenzelmann, S Kirsten, D Schmetzer, B Bischoff, M Roemer, E Kiehl, MG Fauser, AA
Citation: Iaw. Blau et al., Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study, BONE MAR TR, 27(1), 2001, pp. 27-33
Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience
Authors: Basara, N Kiehl, MG Blau, W Romer, E Bischoff, M Schmetzer, B Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience, TRANSPLAN P, 33(3), 2001, pp. 2121-2123
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients
Authors: Basara, N Blau, WI Kiehl, MG Schmetzer, B Bischoff, M Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients, CLIN TRANSP, 14(2), 2000, pp. 121-126
Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study
Authors: Basara, N Schmetzer, B Blau, IW Bischoff, M Gunzelmann, S Kirsten, D Fauser, AA
Citation: N. Basara et al., Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study, BONE MAR TR, 25(4), 2000, pp. 371-376
Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant
Authors: Blau, IW Basara, N Bischoff, M Gunzelmann, S Romer, E Kirsten, D Schmetzer, B Kiehl, MG Fauser, AA
Citation: Iw. Blau et al., Second allogeneic hematopoietic stem cell transplantation as treatment forleukemia relapsing following a first transplant, BONE MAR TR, 25(1), 2000, pp. 41-45
Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants
Authors: Basara, N Jelkmann, W Schmetzer, B Gunzelmann, S Bischoff, M Blau, WI Kiehl, MG Fauser, AA
Citation: N. Basara et al., Plasma thrombopoietin level in patients receiving unrelated and related bone marrow and blood stem cell transplants, THROMB HAEM, 82(6), 1999, pp. 1771-1772
Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation
Authors: Basara, N Markova, J Schmetzer, B Blau, IW Kiehl, MG Bischoff, M Kirsten, D Fauser, AA
Citation: N. Basara et al., Chronic eosinophilic leukemia: Successful treatment with an unrelated bonemarrow transplantation, LEUK LYMPH, 32(1-2), 1998, pp. 189
Risultati: 1-7 |